These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 3099920)

  • 1. Beta blocker treatment for angina with associated bradycardia.
    James MA; Papouchado M; Jordan SC
    Br Med J (Clin Res Ed); 1986 Dec; 293(6560):1476. PubMed ID: 3099920
    [No Abstract]   [Full Text] [Related]  

  • 2. Antianginal effects of atenolol and pindolol in patients with stable effort angina pectoris.
    Antalóczy Z; Kekes E
    Zhongguo Yao Li Xue Bao; 1989 May; 10(3):222-6. PubMed ID: 2609991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of partial agonist activity in beta blockers in severe angina pectoris: a double blind comparison of pindolol and atenolol.
    Quyyumi AA; Wright C; Mockus L; Fox KM
    Br Med J (Clin Res Ed); 1984 Oct; 289(6450):951-3. PubMed ID: 6148991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atenolol, nadolol, and pindolol in angina pectoris on effort: effect of pharmacokinetics.
    Kostis JB; Lacy CR; Krieger SD; Cosgrove NM
    Am Heart J; 1984 Oct; 108(4 Pt 2):1131-6. PubMed ID: 6148873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta-blocker duration of action and implications for therapy.
    Kostis JB
    Am J Cardiol; 1990 Nov; 66(16):60G-62G. PubMed ID: 1978546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Separate and combined effects of pindolol and isosorbide dinitrate in standardized exercise tests of patients with angina pectoris.
    Zetterquist S; Furberg C; Ringqvist I; Söderholm B
    Curr Ther Res Clin Exp; 1975 Feb; 17(2):139-48. PubMed ID: 803427
    [No Abstract]   [Full Text] [Related]  

  • 7. Variability of response to beta receptor blockade for angina pectoris in clinical trials: a study of pindolol.
    Harston WE; Friesinger GC
    Am J Cardiol; 1982 Oct; 50(4):722-7. PubMed ID: 6127028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pindolol: exercise testing and angina.
    Jennings G; Bobik A; Korner PI
    Med J Aust; 1977 Sep; 2(SP2):6-7. PubMed ID: 927283
    [No Abstract]   [Full Text] [Related]  

  • 9. Prindolol (Visken) and alprenolol (Aptin) in angina pectoris: a comparative clinical study with special reference to ergometer working capacity tests.
    Bjerle P; Jacobsson KA
    Curr Ther Res Clin Exp; 1974 Feb; 16(2):101-16. PubMed ID: 4218804
    [No Abstract]   [Full Text] [Related]  

  • 10. Abolition of exercise induced ST depression after exercise training and its recurrence after beta blockade.
    Todd IC; McGuinness JB; Ballantyne D
    Br Heart J; 1988 Feb; 59(2):259-62. PubMed ID: 3342165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The treatment of angina pectoris with the new beta-receptor blocker carteolol. Results of a controlled trial in comparison with pindolol.
    Simon H; Schuppan U
    Arzneimittelforschung; 1983; 33(2a):318-21. PubMed ID: 6340700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tenolol in angina pectoris.
    Shah LS; Merchant SA; Padaria SF; Bisne VV; Gupta KG; Vengsarkar AS
    Indian Heart J; 1990; 42(1):43-5. PubMed ID: 2351398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of an adrenergic beta receptor blockader on exercise tolerance and myocardial function in patients with angina pectoris].
    De Petra V; Di Michele R; Cecchetti E
    Minerva Cardioangiol; 1973 Sep; 21(9):619-24. PubMed ID: 4745004
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of coexistent angina pectoris and hypertension with prindolol.
    Leary WP; Asmal AC
    S Afr Med J; 1975 Jan; 49(1):11-2. PubMed ID: 803324
    [No Abstract]   [Full Text] [Related]  

  • 15. Bopindolol and atenolol in patients with stable angina pectoris. Double-blind randomized comparative trial.
    Hertzeanu H; Shemesh J; Loidl AF; Kellermann JJ
    Cardiology; 1989; 76(4):312-8. PubMed ID: 2572323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Anti-ischemic action of the transdermally applied beta-receptor blocker, mepindolol in patients with stable angina pectoris].
    Bonelli J; Gazo F; Liedtke RK
    Arzneimittelforschung; 1989 Nov; 39(11A):1515-7. PubMed ID: 2576203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bopindolol for the treatment of chronic stable angina pectoris--a clinical study of the relationship between dose and effect.
    Holmes D; Fryda-Kaurimsky Z; Krueger K
    Cardiology; 1990; 77(6):459-65. PubMed ID: 1981493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of sustained release diltiazem (Diltiazem-R) in patients with stable effort angina.
    Kaku T; Himeno E; Nakashima Y; Kuroiwa A
    Artery; 1994; 21(4):193-207. PubMed ID: 8830646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Angina and bradycardia].
    Di Benedetto A; Glorioso R; Cipolla A; Quadra V; Corrao A; Banco E
    Boll Soc Ital Cardiol; 1977; 22(3):347-54. PubMed ID: 617281
    [No Abstract]   [Full Text] [Related]  

  • 20. A new beta receptor blocking agent LB-46 in angina pectoris. (A double blind clinical trial).
    Srivastava BN; Jain PC; Vyas GP
    Indian Heart J; 1972 Jun; 24():Suppl 1:203-4. PubMed ID: 4581428
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.